Ranga Godavarti

Pfizer (United States)

Papers

1

Total Citations

4

H-Index

1

About

Ranga Godavarti is a leading figure in bioprocess development, with a focus on high throughput process development (HTPD) and particle conditioning operations. His work addresses the biotech industry’s urgent need to reduce time to market and development costs while meeting regulatory demands for deeper process understanding. Godavarti’s major contribution lies in pioneering HTPD methodologies that leverage small volumes, parallel processing, and advanced analytics to accelerate the characterization and optimization of bioprocesses. His 2015 paper, "High throughput screening of particle conditioning operations: I. System design and method development," with 4 citations, serves as a foundational reference for integrating HTPD into particle conditioning workflows. This work demonstrates his commitment to enhancing process efficiency and robustness, directly impacting the development of biologics and vaccines. Godavarti’s research has been instrumental in bridging the gap between early-stage process design and scalable manufacturing, making him a key contributor to modern bioprocess engineering. His achievements underscore the transformative potential of HTPD in streamlining biotech innovation.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
High throughput screening of particle conditioning operations: I. System design and method development
4 citations · 2015
📈 Most Prolific Year: 2015 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Pfizer (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago